The Baseline Serum IgG4/IgG3 Ratio Might be a Suitable Marker for Predicting Favorable Treatment Response in Patients with Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)53-54
Number of pages2
JournalJournal of Rheumatic Diseases
Volume28
Issue number2
DOIs
StatePublished - Apr 2021

Cite this